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Abstract
The non-coding microRNAs (miRNA) have tissue- and disease-specific expression patterns. They down-regulate target
mRNAs, which likely impacts on most fundamental cellular processes. Differential expression patterns of miRNAs are
currently being exploited for identification of biomarkers for early disease diagnosis, prediction of progression for
melanoma and other cancers and as promising drug targets, since they can easily be inhibited or replaced in a given cellular
context. Before successfully manipulating miRNAs in clinical settings, their precise expression levels, endogenous functions
and thus their target genes have to be determined. MiR-211, a melanocyte lineage-specific small non-coding miRNA, is
located in an intron of TRPM1, a target gene of the microphtalmia-associated transcription factor (MITF). By transcriptionally
up-regulating TRPM1, MITF, which is critical for both melanocyte differentiation and survival and for melanoma progression,
indirectly drives the expression of miR-211. Expression of this miRNA is often reduced in melanoma samples. Here, we
investigated functional roles of miR-211 by identifying and studying new target genes. We show that MITF-correlated miR-
211 expression levels are mostly but not always reduced in a panel of 11 melanoma cell lines and in primary and metastatic
melanoma compared to normal melanocytes and nevi, respectively. MiR-211 itself only marginally impacted on cell invasion
and migration, while perturbation of some new miR-211 target genes, such as AP1S2, SOX11, IGFBP5, and SERINC3
significantly increased invasion. These results and the variable expression levels of miR-211 raise serious doubts on the value
of miR-211 as a melanoma tumor-suppressing miRNA and/or as a biomarker for melanoma.
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Introduction
Most likely owing to changed sun-tanning behavior, cutaneous
melanoma is rapidly increasing in the industrialized world: an
estimated 76,250 people will be diagnosed with invasive melano-
ma in 2012 in the US, where the incidence increased by 45% from
1992 to 2004 (www.skincancer.org). To this day, molecular
markers that would permit differential diagnosis at early stages,
classification and prediction of disease progression that could help
clinicians to offer more personalized and effective treatment
options are not yet consolidated. In this context, miRNAs have
been extensively studied to become the sought-after biomarkers,
clinical targets, or predictors of cancer and other diseases [1–3].
Profiling of miRNA levels and investigation of functional
consequences of individual or groups of miRNAs is complicated
by their relatively small variations in expression levels (between
1.5–5 fold) [4]. Nevertheless, even small differences in miRNA
expression levels might have profound functional consequences for
cellular growth, proliferation, differentiation, and other funda-
mental cellular programs [5]. Another striking denominator of
miRNA profiling in many cancers, including melanoma, is the
heterogeneity of their basal miRNA levels. The limitations of such
profiling studies have recently been reviewed [6] and can be
attributed to factors such as technical issues, intrinsic cellular
heterogeneity of the clinical samples, different sample types, and
the original driving event for development of melanoma (genetic,
UV radiation, etc.). Therefore, it remains difficult to this day to
summarize existing data in one reliable melanoma-specific
miRNA expression set.
Nonetheless, one of few miRNAs that seem specific to the
melanocyte lineage is miR-211 [7,8]. Most studies concur on a
down-regulation or a complete loss of this miRNA in the majority
of analyzed melanoma patient samples and cell lines when
compared to normal skin, nevi or NHEM (normal human
melanocytes) [9–21]. On the other hand, Mueller et al. did not
detect a differential expression of miR-211 in melanoma cell lines
versus normal melanocytes [22] and even elevated miR-211 levels
in melanoma samples relative to nevi have been described [23];
high expression levels of miR-211 have further been used to
discriminate between melanoma and other cancer cell lines [7,8].
MITF (microphthalmia-associated transcription factor), the
master regulator of melanocyte proliferation, survival and
differentiation, has intricate regulatory roles in melanoma
development [24]. Described as a ‘‘lineage addiction’’ oncogene,
MITF is amplified in 10–20% of melanomas; however, MITF has
also been attributed tumor-suppressive roles [25]. One of the
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transcriptional targets of MITF, Melastatin/TRPM1, intronically
hosts the gene for miR-211 [11]; hence miR-211 is a direct
transcriptional ‘‘co-product’’ of MITF activity.
Here, we report that miR-211 expression was reduced in most
but not all melanoma cell lines and patient samples compared to
normal melanocytes, confirming the generally reported reduction
of miR-211 levels in melanoma samples. We furthermore screened
16 ‘‘new’’ potential target genes, and show that RAB22A, AP1S2,
SERINC3 and others are targeted by miR-211. Silencing of the
new targets AP1S2, IGFBP5, and SOX11 resulted in reproducible
effects on melanoma cell invasion and migration but strikingly,
miR-211 alone did not influence proliferative and invasive growth
characteristics significantly. Levels of miR-211 always correlated
with those of MITF and TRPM1. Therefore, we speculate that
MITF is the key factor influencing melanoma cell behavior by
directly driving transcription of its melanocyte-lineage specific
target genes (MLANA, TYR, TRPM1 etc.) as well as by indirectly
up-regulating the intronic miR-211, which in turn down-regulates
a number of target genes that may altogether participate in
modulating melanoma growth behavior.
Materials and Methods
Ethics Statement
The sample collection was approved by the ethical review board
of Ethics commission Freiburg (reference EK196/09) and written
informed consent was obtained from healthy controls and patients.
Cell Lines and Cell Culture
Eleven melanoma cell lines were used [26]: Wm35 and Wm9
(paired cell lines, derived from primary and metastatic sites
respectively) (Dr. M. Bo¨hm, Mu¨nster, Germany), FM55/P and
FM55/M1 (paired cell lines, derived from primary and metastatic
sites respectively) (European Searchable Tumor Line Database
and Cell Bank), IGR39 and IGR37 (paired cell lines, derived from
primary and metastatic sites respectively) (Deutsche Sammlung
von Mikroorganismen und Zellkulturen), A375 (derived from a
metastatic site) (American Type Culture Collection), 1102 (derived
from a metastatic site) (Dr. M. Kortylewski, City of Hope,
California), MeWo (derived from a metastatic site) (Dr. D.
Schadendorf, Essen, Germany) and MelIm (derived from a
metastatic site) and MelJuso (derived from a primary tumor) (Dr.
A. Bosserhoff, Regensburg, Germany). All cells were maintained in
RPMI 1640 supplemented with 10% FCS (PAA Laboratories,
Austria), 50 mg/mL penicillin, 100 mg/mL streptomycin, and
0.5 nmol/L L-glutamine. Normal human epidermal melanocytes
NHEM-M2 from lightly pigmented adult skin and NHEM-M2-
F1, NHEM-M2-F2, NHEM-M2-F3 (PromoCell, Germany), from
lightly, medium and darkly pigmented neonatal foreskin, respec-
tively, were maintained in serum- and PMA–free melanocyte
growth medium M2 (PromoCell, Germany). Hek293T (Invitro-
gen) and prostate cancer PC3 cells were grown in DMEM
supplemented with 10% FCS, 50 mg/mL penicillin, 100 mg/mL
streptomycin and 2.5% Hepes. All cells were grown in a
humidified atmosphere with 5% CO2 supply and were routinely
tested by PCR to be Mycoplasma negative. Unless stated otherwise,
media and reagents were purchased from LONZA (Belgium).
Patient Samples
Skin tissue samples from patients with either benign nevi or
melanoma were collected at the Dermatology of the University
Hospital of Freiburg (Germany) and histopathologically examined
to confirm clinical diagnoses. Upon excision, tissues were fixed in
FFPE according to standard dermato-histopathologic techniques.
In total, 4 pools of benign nevi (RNAs of two different donors
each), 9 primary and 12 subcutaneous melanoma metastasis
patient samples were analyzed (age and gender information is as
described before [26]). Additionally, 2 breast cancer FFPE samples
from two patients were included in this study.
Total RNA Extraction and Quality Control
Total RNA of cell lines was extracted using TRIsure (Bioline
USA, Inc.) and treated with DNaseI (New England Biolabs)
following each manufacturer’s instructions. For whole-transcrip-
tome microarray analyses, total RNA was extracted using the
miRNeasy kit (Qiagen) according to the manufacturer’s protocol
with additional on-column DNaseI digestion. For total RNA
extraction of FFPE samples, five scalpel-scraped slices of FFPE
tissue were pooled and processed using the RT2-FFPE RNA
Extraction kit (Qiagen) according to the supplied protocol.
Quantity and purity of RNA samples were assessed using a
NanoDrop ND-2000 Spectrophotometer.
Microarrays and Data Analysis
IGR39 cells, seeded at a density of 66104 cells/well in 12-well
culture plates, were transfected with 5 nM of miR-211 mimic or
negative control (NCM) as described in the main text. Samples for
total RNA extraction were collected 48 h after transfection. RNA
quality was assessed using RNA 6000 NanoChips with the Agilent
2100 Bioanalyzer (Agilent, Paolo Alto, USA). Gene expression
profiling experiments using GeneChipH Human Gene 1.0 ST
arrays and miRNA profiling using GeneChipH miRNA arrays
(Affymetrix, Santa Clara, CA, USA) were performed on two
independent samples at the CRP-Sante´ Microarray Unit (Lux-
embourg) as described before [27] and according to standard
protocols. Microarray data are available in the ArrayExpress
database (www.ebi.ac.uk/arrayexpress) under accession number
E-MEXP-3749. Standard pipeline from the PartekH Genomics
SuiteTM (Partek GS) software was used for analysis of data files.
Lists of genes were generated by pair-wise comparison of
expression data sets (negative control vs. mimic treated samples
at 48 h).
miRNA and mRNA Detection and Relative Quantification
by qPCR
Briefly, 250 ng of total RNA from cell lines and FFPE tissues
were reverse transcribed in a 10 ml reaction volume with the
miScript Reverse Transcription kit (Qiagen) following the supplied
protocol. Real-time PCR detection of mRNAs and mature
miRNAs was carried out on a CFX96 Detection System (Bio-
Rad). For quantification of mature miRNAs, 5 ng RNA input, 26
iQ SYBR Green Supermix (Bio-Rad) and 106 miRNA-specific
primer assay (Qiagen) were used. For mRNA detection, 50 ng
RNA input, 26 iQ SYBR Green Supermix and 5 pmol gene-
specific primer pairs were used (primer sequences are listed in
Table S1). Specificity of the qPCR primers was assessed by a post-
qPCR melting curve analysis. If not stated otherwise, Ct-values for
mRNA and miRNA species were normalized to three reference
genes: TBP (TATA binding protein), HPRT1 (Hypoxanthine
phosphoribosyltransferase 1) and cyclophilin A for mRNAs and
RNU1A, RNU5A (RNA, U1A/5A small nuclear) and
SCARNA17 (small Cajal body-specific RNA 17) for mature
miRNAs. Based on the geometric mean of the three reference
genes, a normalization factor was calculated for each sample using
geNorm, a VBA applet for Microsoft Excel. The relative amount
of each target in each sample was then corrected by dividing its
amount by the corresponding normalization factor. Fold changes
miRNA-211 Role in Melanoma Cell Invasion
PLOS ONE | www.plosone.org 2 September 2013 | Volume 8 | Issue 9 | e73473
were calculated by dividing the normalized relative amount of
treated samples with the normalized relative amount of the control
sample. Statistical significance was assessed with t-test or one-way
ANOVA followed by a Dunnett Post-Hoc test. P values of ,0.05
(*), ,0.01 (**) and ,0.001 (***) were considered significant.
Western Blot Analysis
Western blots were performed as described before [27] to detect
successful transfection and subsequent expression of the MITF
protein in A375 cells and following siRNA-mediated silencing of
MITF in FM55/M1 cells. The following primary antibodies were
used: anti-MITF (Clone C5, Sigma-Aldrich, 1:500), anti-RAB22A
(Proteintech, 1:2000) and anti-a-tubulin (Santa Cruz, 1:2500).
HRP-labeled secondary antibodies were purchased from Cell
Signaling Technology (Boston, MA).
MITF Transient Transfection
A375 cells were seeded at a density of 36105 cells/well in 6-well
culture plates (Greiner) and were transfected 24 h later with 1 mg
of pCMV-SPORT6-MITF expressing vector (cDNA clone
MGC:75121 IMAGE:6066096; Open Biosystems) using the
TransIT-LT1 (Mirus) transfection reagent. RNA and protein
lysates were harvested at 24 and 48 h after transfection and
processed as described in Supplementary Materials and Methods.
Oligonucleotide Transfections
56104 cells/well were seeded in 6-well culture plates (Greiner)
and transfected after 24 h with 5 nM miRNA (10 nM for
NHEMs) mimic or mimic negative control (NCM) or 75 nM
ON-TARGET siRNA or siRNA negative control (siCtrl) using the
HiPerfect transfection reagent according to the manufacturer’s
protocol (Qiagen), with the exception of MITF siRNA for which
105 cells/well were seeded in 6-well plates and LipofectamineTM
RNAiMAX was used as transfection reagent following the
supplied guidelines (Life Technologies). Treated cells were assayed
24, 48 and 72 h after transfection. MiRNA mimics were
purchased from Qiagen and all ON-TARGET siRNAs from
Dharmacon.
Dual Luciferase Reporter Gene Assays
Partial sequences of the RAB22A and AP1S2 39UTRs
containing putative miR-211 target sites were PCR-amplified
from A375 cDNA (ThermoScript RT kit, Invitrogen) and cloned
into the pmirGLO Dual Luciferase miRNA target expression
vector (Promega) downstream of the firefly luciferase gene. The
miR-211 full complementary (FC) (positive control) sequence as
well as the RAB22A, AP1S2, SERINC3, KCNMA1, M6PR,
SSRP1, PDE3A, LIFR, IGFBP5, SOX11 and SOX4 predicted
miR-211 binding sites were cloned individually into the pmirGLO
vector (primer and oligonucleotide sequences are listed in Table 1).
A375 cells were seeded at a density of 56104 cells/well in 24-well
plates 24 h prior to transfection. Cells were transiently co-
transfected with 500 ng plasmid and 5 nM miR-211 mimic or
negative control for 48 and 72 h using Dharmafect Duo (Thermo
Scientific). Samples were lysed with 16 Passive Lysis Buffer
(Promega) and luciferase activities were measured consecutively
using the Dual Luciferase Reporter Assay System (Promega)
according to the manufacturer’s instructions. The Firefly/Renilla
activity ratios of mimic-treated samples were calculated and
normalized to the respective ratios of the negative control-treated
samples for each construct and each time point. Significance was
assessed by a paired t-test.
Invasion and Migration Assays
Different melanoma cell lines, seeded at a density of 26104
cells/well in collagen I-coated (200 mg/ml, Millipore) 96-well
plates (Essen Imagelock, Essen Bioscience), were transfected after
24 h with 25 nM miR-211 mimic or NCM, or with 375 nM
siRNA or the negative siCtrl as described above. 24 h after
transfection, when cells had reached 80–90% confluence, a wound
was scratched across each well with the Cellplayer 96-well
woundmaker (Essen Bioscience). To study invasion, cells were
covered with 50 ml type I collagen solution (1 mg/ml collagen in
normal growth medium) that was allowed to gel for 30 min at
37uC. This matrix was overlaid with additional 100 ml normal
growth medium. To study migration, 150 ml normal growth
medium (without collagen) was added to the cells. Wound
confluency was monitored with the Incucyte LiveCell Imaging
System (Essen Bioscience) by measuring cell confluency every 3 h
for a total of 72 h; it was quantified with the relative wound
density v1.0 metrics of the included analysis software: invasion was
monitored in wells containing a collagen matrix while wells
without collagen were used for analysis of migration events. 24, 48
and 72 h after scratching, RNA was extracted from transfected
cells (from 4 pooled 96-wells) to determine expression levels of
miR-211 or the silenced target genes by qPCR. Wells with
inappropriate or uneven scratches were excluded from analysis.
Results
In order to identify miRNAs differentially expressed in
melanoma cells, we have performed miRNA microarray analyses
using IGR39, IGR37 (primary and metastatic melanoma cell lines
derived from the same patient) and NHEM (normal human
melanocytes). We have previously reported on several of those
differentially expressed miRNAs [26]. The growing number of
studies suggesting an important role of miR-211 in melanoma cells
led us to re-analyze our miRNA array data. Interestingly, miR-211
levels were undetectable in NHEM and IGR39, while a strong
expression was scored in IGR37 metastatic cells. These unexpect-
ed results contradicted some previously published data and
prompted us to investigate miR-211 expression levels and target
genes in more detail.
Expression Profiling of miR-211
MiR-211 is located in intron 6 of the TRPM1 gene on
chromosome 15. Interestingly, miR-204, which shares the same
seed region with miR-211 and therefore many predicted target
genes, lies in intron 6 of TRPM3, which also encodes a calcium
channel protein with similar functions to TRPM1. Because of this
intriguing connection, we initially profiled both miRNAs. Figure 1
illustrates completely different expression profiles for both
miRNAs in melanoma cell lines and patient samples. Six of 11
tested cell lines had absent or very low levels of miR-211 compared
to NHEM; however, IGR37 (which had been used in our initial
miRNA arrays) and FM55/P and FM55/M1 (primary and
metastatic tumors from the same patient) had much higher levels
of miR-211 than NHEM, indicating that there is intrinsic
variation in the expression levels of this miRNA (Figure 1A).
Additionally, we detected a general down-regulation of miR-211,
but not of miR-204, in samples from primary and metastatic
melanoma patients as compared to nevi. Both miR-211 and miR-
204 were not expressed in 2 breast cancer samples (Figure 1B).
The correlation and inter-dependency of MITF, TRPM1 and
miR-211 has been demonstrated before [10–12]. We confirm this
strong correlation in 10 of 11 tested melanoma cell lines, which
clearly supports the idea that MITF drives expression of TRPM1
miRNA-211 Role in Melanoma Cell Invasion
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and by doing so it up-regulates miR-211, an intronic passenger of
this gene (Figure 1C). MITF over-expression in cells with very low
endogenous MITF induced expression of TRPM1, miR-211 and
of MLANA, a direct target gene of MITF, which was used to
control for functionality of transfected MITF (Figure S1A). Vice
versa, silencing of MITF in cells, which normally express this
transcription factor, clearly reduced expression of TRPM1, miR-
211, and MLANA (Figure S1B). These results again confirm that
miR-211 expression is strongly dependent on functional MITF.
Therefore, it is the absence or presence of functional MITF in a
given cell line or patient sample that determines the amounts of
miR-211 and consequently expression levels of miR-211 target
genes.
Identification of miR-211 Target Genes
To obtain an overview of those potential target genes, whose
mRNA is degraded or down-regulated by miR-211 (opposed to
targets for which only protein levels would be altered), we
transfected IGR39 melanoma cells with miR-211 mimics or
negative controls and analyzed samples by mRNA arrays.
Figure 2A shows that expression levels of the vast majority of
mRNAs was not or only marginally altered following miR-211
mimic treatment, while some were strongly down- or up-regulated
indicating a potential connection with miR-211 levels. Focusing on
down-regulation events, we compiled a list of tentative targets
from our own array analysis, from literature and using several
miRNA target gene prediction algorithms (Table 1).
Next, we analyzed by qPCR expression changes of selected
putative target genes following miR-211 mimic treatment in 6
different cell lines and NHEM samples from 3 different donors
(Figure 2B) after thorough optimization of miR-211 mimic
concentrations: titration experiments over a period of 72 h showed
that concentrations of 5 nM miR-211 mimic were sufficient to
induce significant effects on target gene expression, exemplified by
robust down-regulations of RAB22A, SERINC3 and AP1S2 over
time (Figure S2). Consequently, 5 nM miR-211 mimics were
applied throughout the study to all cancer cell lines (10 nM was
used for primary NHEM cells). Figure 2B depicts strong down-
regulatory effects of miR-211 mimic on mRNA levels of the newly
identified putative RAB22A, SERINC3 and AP1S2 target genes in
different cell lines and NHEMs, which became visible after 24 h
and remained stable for up to 3 days. Effects on IGFBP5 (insulin-
like growth factor binding protein 5) were generally less consistent
in melanoma cells but significant in prostate cancer cells (PC3).
Eleven additional potential targets have been analyzed by qPCR
after mimic treatment (data not shown) and results are summa-
rized in Table 1.
To further analyze corresponding protein levels, we tested
several commercially available antibodies against the new miR-
211 targets however, except for RAB22A (Figure S2), antibodies
were mostly unspecific and could not be used for reliable detection
and quantification of protein levels (data not shown).
Next, we reduced endogenous MITF levels by siRNA treatment
in order to verify the correlation of MITF and miR-211 levels
followed by analysis of mRNA levels for selected target genes
(Figure S3). However, only RAB22A and SERINC3 levels
increased simultaneously to a decrease in miR-211 due to
silencing of MITF suggesting a direct interaction between miR-
211 and these target genes. Even though we only used melanoma
cell lines, the different experimental approaches demonstrate that
results vary with respect to individual target genes. The
interpretation of whether a mRNA is directly targeted by a given
miRNA does not only depend on the cellular background but even
more so on experimental assays and conditions.
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Direct Interaction of miR-211 with Target Gene mRNAs
To determine whether the above-observed effects are due to
direct interactions between miRNA-211 and its target mRNAs in
melanoma cells, we performed extensive luciferase reporter gene
assays in A375 cells with partial 39UTRs and individually-cloned
single miR-211 binding sites of the respective targets. Regarding
the targets SERINC3, IGFBP5, the GTPase RAB22A and the
adaptin AP1S2, luciferase activity decreased after transfection of
miR-211 mimics compared to negative controls (NCM) (Figure 3).
Additional target genes for which we have observed decreased
luciferase activity are shown in Figure S4. KCNMA1 has
previously been described as a direct miR-211 target in A375
cells [10]. However, in our hands and applying a dual luciferase
Figure 1. Expression profiling of miR-211 and co-expressed proteins. (A) RNA of primary melanocytes (NHEM-M2) and 11 different
melanoma cell lines was analyzed for relative miR-211 (blue) and miR-204 (red) expression levels by qPCR. Statistical significance was assessed with
ANOVA (repeated measures) followed by a Dunnett Post-Hoc multiple comparison test. P values of ,0.05 (*), ,0.01 (**) and ,0.001 (***) were
considered significant. (B) RNA of FFPE patient samples from 4 nevi, 9 primary and 12 metastatic melanoma samples and 2 breast cancer samples
were analyzed as above. (C) Co-expression of MITF, TRPM1 and the intronic miR-211 was confirmed in the same cell lines and statistical significance
was tested as in (A). Except for FFPE patient samples, all experiments were performed at least in biological triplicates.
doi:10.1371/journal.pone.0073473.g001
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reporter gene assay, only non-significant effects of miR-211 on this
calcium channel gene were scored (Figure S4).
Effects of miR-211 and its Target Genes on Melanoma
Cell Invasion and Migration
Interestingly, several groups have previously described negative
effects of miR-211 on invasion and/or migration of melanoma
cells [10–12]. In order to reproduce and further investigate these
suppressive effects on invasion, we introduced miR-211 mimics
into several melanoma cell lines with high or absent levels of
endogenous miR-211 (Figure 1A). Surprisingly, miR-211 mimic
treatment did not reduce cell invasion and/or migration in all
tested cell lines, but rather increased invasion slightly but
reproducibly (Figure 4 and S5). Migration of melanoma cell lines
was also only marginally altered by miR-211 mimics; cell
proliferation was not affected at all (data not shown).
Finally, we investigated a potential involvement of the newly
identified, individual miR-211 target genes in migration and
invasion of melanoma cells. Intriguingly, siRNA-mediated abla-
tion of AP1S2, IGFBP5, SERINC3 and SOX11 significantly
increased invasion by up to 40%. Migration was augmented up to
30 h of assay time for only AP1S2 and IGFBP5 in A375
melanoma cells (Figure 5). Inhibition of RAB22A, the most
prominent direct miR-211 target (Table 1) did, however, not
influence cell growth characteristics. Silencing of PDE3A and
SSRP1 had only minor effects on cell invasion and none on
migration. Table 1 summarizes our own data on 16 putative miR-
211 target genes that we have identified and compiled using
microarray data from miR-211 mimic-treated melanoma cell
lines, experimental data from different assay formats and several
target gene prediction software tools (TargetScan, Pictar, MiRan-
da, DIANA). To complete this comprehensive miR-211 target
gene summary, we also listed 13 previously described targets from
different cell lines and tissues. Taken together, we identified and
characterized several genes that are specifically down-regulated by
miR-211, a miRNA, which is transcriptionally induced by MITF.
We only observed minor or no effects of miR-211 itself on growth
behavior of melanoma cells, challenging previous notions of a
strong suppressive effect of miR-211 on cell invasion. Nevertheless,
inhibition of some of the new target genes had robust and
reproducible effects on the invasive behavior of melanoma cells.
Discussion
MicroRNAs are major players in post-transcriptional regulation
of tissue- and disease-specific gene expression. The importance of
miRNAs as master gene regulators, as potential diagnostic markers
for many different diseases and as targets for future therapeutic
applications form the basis for ongoing research on the relevance
of miRNAs in melanoma and other cancers [3].
A number of recent studies have reported modified expression
levels of miR-211 in melanoma cells and/or have investigated the
functional roles of miR-211 and its target genes [10–12,17,18]. A
clear correlation has been demonstrated between MITF and miR-
211, which we also confirm here: MITF transcriptionally activates,
amongst many other genes, the calcium channel TRPM1
(melastatin) and by doing so, the intronic miR-211 is simulta-
neously up-regulated. In the majority of melanoma cell lines and
patient samples, MITF and miR-211 levels seem reduced
compared to normal melanocytes or nevi. However and
irrespective of their invasive capacities, a considerable proportion
of melanoma samples (in our study nearly 50%, Figure 1) have
high MITF and correspondingly high miR-211 expression levels
compared to healthy cells [10,16]. We show that miR-211
Figure 2. Identification of miR-211 target genes. (A) To identify
new miR-211 target genes, miR-211-negative IGR39 melanoma cells
were transfected with 5 nM miR-211 mimic or negative control (NCM)
for 48 h. RNAs from two independent samples were extracted and
analyzed separately by Affymetrix mRNA arrays. The scatter plots show
ratios of normalized and averaged arbitrary fluorescence units (AFU)
from two independent arrays between NCM- and mimic-treated cells
for all mRNAs. Top-regulated genes are listed in grey boxes. (B)
Expression levels (qPCR) of 4 selected and putative miR-211 targets
RAB22A, SERINC3, AP1S2 and IGFBP5 after 5 nM miR-211 mimic or NCM
(or 10 nM for primary melanocytes NHEM) treatment for 24, 48 and
72 h +/2 SEM are shown. Levels of NCM-treated cells were set to 1.
Significance was tested with a t-test and p values are as described in
Figure 1.
doi:10.1371/journal.pone.0073473.g002
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expression was indeed reduced but only in 6 of 11 melanoma cell
lines and in most but not all melanoma patient samples. For all
tested cell lines (except Wm35), we found that miR-211 levels
correlated with MITF and thus TRPM1 levels (Figure 1C, Figure
S1). In this context, the initially described tumor-suppressive and
anti-invasive properties of TRPM1 [28] have recently been shown
to be executed by its intronic miR-211 (and not by TRPM1 itself)
via down-regulation of the miR-211 direct and indirect targets
TGFBR2, NFAT5, and IGF2R [11].
To date, only few target genes of miR-211 in melanoma cells
have been described. For instance, the miR-211-mediated down-
regulation of the calcium ion-regulated potassium channel
KCNMA1, whose expression is up-regulated in metastatic
melanoma, was reported to account for the anti-invasive effects
of this miRNA [10]. Here, using a dual luciferase assay,
KCNMA1 was also regulated by miR-211 in the same cell line
(A375), albeit to a much lower extent. The transcription factor
BRN-2, which can repress MITF expression, is also targeted by
miR-211. It was reasoned that this negative feedback loop on
MITF, enforced by the loss of miR-211, would keep melanoma
cells in a de-differentiated, pro-invasive state [12].
Although previous studies have reported tumor-suppressing
traits of miR-211 by decreasing invasion [11,12], we show here
that miR-211 itself hardly had any measurable and reproducible
effects on invasion or migration (Figure 4), for which we used a
next generation live Imaging system (IncuCyte). The IncuCyte
monitors long-term cellular growth, behavior, and morphology in
a 96-well format allowing for accurate statistical analysis of total or
single invasion or migration events. When introducing miR-211
mimics, growth behavior was not significantly altered in a
melanoma cell line that endogenously expresses this miRNA
while small pro-invasive and pro-migratory effects were scored in 3
melanoma cell lines that do not express endogenous miR-211. In
agreement with this, Boyle and colleagues reported that over-
expression of miR-211 reduced invasion only in MITF- and thus
miR-211-positive cells, however, when cells expressing low levels
of MITF and miR-211 were transfected with miR-211 mimic, the
authors observed increased invasion of the melanoma cells [12]. In
this context, some reports have also stated oncogenic roles for
miR-211 in non-melanocytic tissues: in oral carcinoma, miR-211
expression was correlated with poor prognosis [29] and Cai et al.
demonstrated that miR-211 promoted colorectal cancer cell
growth in vitro and in vivo [30]. Most cancers become life-
threatening once they have metastasized and therefore, the ability
to invade surrounding tissue represents one of the key events
determining the fate of a cancer patient [31]. Concerning the role
of MITF, we have initial data indicating reduced invasion and
migration of IGR37 melanoma cells following MITF silencing by
siRNAs (Figure S6). Proliferation, however, was neither influenced
in MITF-silenced cells nor in miR-211 mimic-treated cells (data
not shown). Therefore, it will be crucial to more precisely define
Figure 3. Luciferase reporter gene assays confirm new direct
targets of miR-211 in melanoma cells. A luciferase reporter vector
containing indicated stretches of the target 39UTR or single binding
sites (BS) for miR-211 (depicted by schemes above the graphs) were
transfected together with 5 nM miR-211 mimic or NCM into A375
melanoma cells. After 48 and 72 h, luciferase activity was measured. The
full complementary (FC) sequence of miR-211 was cloned into the
luciferase vector and served as a positive control. Shown are ratios of
mimic/NCM-treated cells. Activity of NCM-treated cells was set to 1 with
bars representing the average of at least 3 biological replicates per time
point, +/2 SEM. Significance was tested by a paired t-test with p values
as described above.
doi:10.1371/journal.pone.0073473.g003
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the role of MITF and miR-211 in order to consolidate the true
relevance of this microRNA for melanoma cell invasion.
Several new miR-211 targets were identified: RAB22A, AP1S2,
SERINC3, IGFBP5, PDE3A, M6PR, SSRP1 and SOX11 were
generally down-regulated by miR-211, however, the degree of
regulation depended on the experimental assays. Upon silencing of
several of these target genes, we observed clearly enhanced
invasive properties, suggesting that high levels of miR-211 would
indeed favor an invasive phenotype. However, miR-211 itself did
not modulate growth characteristics of several melanoma cell lines.
This suggests that either miR-211 alone has no ability to actively
perturb cell invasion, migration and proliferation or other yet
unidentified miR-211 targets counteract the effect of the mimic in
our experimental setup or the action of several miRNAs with
similar functional targets would be required to achieve a robust
effect. In this context, we subjected the new and previously
described miR-211 target genes to Ingenuity pathway analysis
(IPA) but no common functional pathways were found indicating
independent roles or a yet unknown interplay of these candidates
in melanoma cells. Nevertheless, 3 of the top 4 miR-211 targets
appear to be involved in endosomal trafficking (Table 1), a
common function worth pursuing.
As has been comprehensively reviewed by several authors
[6,19,25,32], MITF not only is the master regulator of healthy
melanocytes, it also plays important roles in melanoma develop-
ment. Depending on MITF expression levels, melanoma cells can
switch between proliferative and invasive programs [33]. Howev-
er, many different known and unknown microenvironmental as
well as genetic factors upstream or downstream of MITF can
influence its activity and target gene selectivity. If we can
determine more precisely what influences different MITF levels
in melanoma or if we could modulate MITF levels themselves, we
might be able to better predict the behavior and progression of
melanoma. The complex interplay of MITF with its direct targets,
together with MITF-dependent up-regulation of miR-211, which
in turn targets several genes that partake in important cellular
processes, is likely to determine melanoma cell fate. Since effects of
isolated miR-211 itself and some of its individual target genes are
rather small, it is reasonable to assume that only the combination
of effects is sufficient to alter growth and proliferation character-
istics of melanoma cells.
Supporting Information
Figure S1 MiR-211 expression is driven by MITF. (A)
A375 melanoma cells, which have no endogenous MITF
(Figure 1), were transfected with a MITF expression vector
(+MITF) or with a negative control (ctrl). After 24 and 48 h, RNA
was extracted and expression levels of MITF, MLANA and
TRPM1 (direct MITF targets) and miR-211 were analyzed by
qPCR. MLANA, TRPM1 and miR-211 were undetectable in ctrl-
Figure 4. MiR-211 has no significant effects on melanoma cell
invasion and migration. Four melanoma cell lines were transfected
with miR-211 mimic (solid lines) or NCM (dotted lines); successful mimic
transfection was confirmed by qPCR in all samples (Figure S5). After
24 h, a scratch/wound assay was performed and cells were grown for
up to 72 h. To study invasion (red lines), cells were covered with a
collagen matrix after wound scratching; to study migration (blue lines),
cells were grown in wells without a collagen matrix containing only
normal growth medium. Invasion and migration were monitored by
measuring wound closure every 3 h for a total of 72 h with the Incucyte
LiveCell Imaging System (Essen Bioscience). Basal levels of miR-211 in
these cell lines are shown in Figure 1. The graphs depict averages from
two biological replicates each including at least quadruplicate samples
+/2SEM. In cells without endogenous miR-211 (MeWo, 1102, and
A375), the mimic treatment caused a very small but reproducible
increase in invasion; in IGR37 (high endogenous miR-211), a further
increase of miR-211 by transfection did not affect invasion/migration at
all.
doi:10.1371/journal.pone.0073473.g004
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treated cells. Western Blots (below) confirmed over-expression of
MITF. (B) Silencing of MITF was performed in FM55/M1
melanoma cells (with high levels of endogenous MITF, Figure 1)
with siRNA directed against MITF (+siMITF) or a negative
control siRNA (+NC). After 24, 48 and 72 h RNA was extracted
and analyzed as in A). Western blots confirmed efficient down-
regulation of MITF protein expression after 24 h up to 72 h. For
qPCR, an average of 4 biological replicates each consisting of 2
technical replicates are shown (except for TRPM1 detection after
MITF transfection, for which 2 biological replicates were
analyzed). A paired t-test was used to determine significance and
p values of,0.05 (*), ,0.01 (**) and ,0.001 (***) were considered
significant. These results confirm that MITF drives TRPM1 and
subsequently the expression of intronic miR-211 as has been
shown before [11].
(PPTX)
Figure S2 Titration of miR-211 mimic and NCM
concentrations followed by analysis of putative miR-
211 target expression levels. A375 melanoma cells were
transfected with different concentrations of miR-211 mimics and
NCM for 24, 48 and 72 h; concentrations ranged from 50 nM to
0.5 nM. A Western blot showing biological duplicates of miR-211-
mediated down-regulation of RAB22A is depicted below the bar
chart (RAB22A was the only potential target, for which a specific
antibody was available). The top graph shows tracking of miR-211
after over-expression and below, different graphs depict mRNA
expression levels of selected putative miR-211 targets (RAB22A,
AP1S2, SERINC3). Levels of NCM-treated cells were set to 1.
Average of 3 biological replicates +/2 SEM are shown. Statistical
analysis of miR-211 tracking: repeated measures ANOVA
followed by Bonferroni Post-Hoc Multiple Comparison test
(NCM vs 211 M); targets: paired t-test (NCM vs 211 M per time
point per amount). P values of ,0.05 (*), ,0.01 (**) and ,0.001
(***) were considered significant.
(PPTX)
Figure S3 siRNA-mediated ablation of MITF shows
effects on two miR-211 target genes. FM55/M1 melanoma
cells with high endogenous MITF levels were treated for 24, 48
and 72 h with siRNA directed against MITF. RNA was extracted
and miR-211 as well as selected target gene mRNA levels were
analyzed by qPCR. Blue bars depict target gene mRNA levels,
while the black line shows endogenous mir-211 expression levels
measured in the same samples. Average of 4 biological replicates
each consisting of 2 technical replicates is shown +/2 SEM of
negative ctrl vs. siMITF); significance was tested with a paired t-
test (p values as above). Only RAB22A and SERINC3 levels show
a negative correlation with lowered miR-211 amounts due to
silencing of MITF, suggesting a direct interaction between miR-
211 and these two target genes. Although AP1S2, M6PR and
SSRP1 were directly targeted by miR-211 in reporter gene assays,
in this experimental setup their expression levels showed no
obvious inverse correlation with miR-211 levels.
(PPTX)
Figure 5. siRNA-mediated down-regulation of new miR-211
targets has an impact on melanoma cell invasion and
migration. A375 cells were transfected with siRNAs directed against
selected miR-211 targets. After 24 h, a scratch/wound assay was
performed as described in Figure 4. To ensure efficient siRNA-mediated
down-regulation of target mRNAs, qPCR was performed on total RNA
(extracted from 4 pooled wells for each treatment) at 24, 48 and 72 h
after transfection in the invasion and migration wells (small inlets,
upper left corners). Representative graphs of four biological replicate
experiments are shown. Error bars show STD from at least 4 technical
replicates for each measurement.
doi:10.1371/journal.pone.0073473.g005
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Figure S4 Luciferase reporter gene assays confirm
more new direct targets of miR-211 in melanoma cells.
A luciferase reporter vector containing the single binding sites (BS)
for miR-211 of the target genes was transfected together with
5 nM mimic or NCM into A375 cells. After 48 and 72 h,
luciferase activity was measured. The different graphs show
luciferase activity in targets with 1, 2 or 3 binding sites for miR-
211. Depicted are the ratios of mimic/NCM treated cells. Activity
of NCM treated cells was set to 1, and averages of at least 3
biological replicates per time point, +/2 SEM are shown.
Significance was tested with a paired t-test with p values as
described before. SSRP1, PDE3A, LIFR, M6PR, SOX4 and
SOX11 have single, two or three 39UTR binding sites for miR-
211 and all seem to be direct targets of miR-211 with more or less
significant down-regulations following 211-mimic treatment.
KCNMA1, a previously described direct target of miR-211 [10],
has two binding sites, both of which seem to be targeted by miR-
211, albeit with low efficiency.
(PPTX)
Figure S5 Tracking of mimic transfections. Four mela-
noma cell lines were transfected with miR-211 mimic (red lines) or
NCM (blue lines) and migration and invasion was measured as
shown in Figure 4. Successful mimic transfection was confirmed by
qPCR in all samples with grey bars representing NCM control
transfections and blue bars showing miR-211 mimic transfections
in either invasion (light blue) or migration (dark blue) experiments.
(PPTX)
Figure S6 siRNA-mediated ablation of MITF influences
melanoma cell invasion and migration. A) To ensure
efficient siRNA-mediated down-regulation of MITF and its
targets, qPCR was performed on total RNA (extracted from 4
pooled wells for each treatment) at 24, 48 and 72 h after
transfection in the invasion and migration wells. B) IGR37
melanoma cells with high endogenous MITF levels were
transfected with siRNAs directed against MITF. After 24 h, a
scratch/wound assay was performed as described in Figure 4.
Representative graphs of three biological replicate experiments are
shown. Error bars show STD from at least 4 technical replicates
for each measurement.
(PPTX)
Table S1 Oligonucleotides and Primers for 39 UTR
cloning (Luciferase assays) and qPCR Primers.
(DOCX)
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